✦ LIBER ✦

Preemptive and prophylactic ganciclovir therapy for CMV infection in heart transplant patients

✍ Scribed by M.J Paniagua; M.G Crespo-Leiro; J.A Rodriguez; S Fojón; M.C Zúñiga; A Cañizares; R Rey; J.J Cuenca; A Juffé; A Castro-Beiras

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does prophylactic ganciclovir therapy af

✍ M Mueller; J Groetzner; I Kaczmarek; F Reisch; P Landwehr; P Ueberfuhr; B Meiser 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Prophylactic and preemptive therapies fo

✍ Norah A. Terrault 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Foscarnet and ganciclovir combination th

✍ B. Salzberger; G. Fätkenheuer; A. Schwenk; C. Franzen; O. Cornely; M. Schrappe; 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 678 KB

Hyperimmune IVIG may be advantageous in

✍ C.D Thomas; R Radovancevic; E.L Ford; B Radovancevic; O.H Frazier 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Role of CMV antigenemia directed preempt

✍ S Husain; K.R McCurry; J.H Dauber; R Zomak; P Williams; S Kusne 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Efficacy and limitations of preemptive t

✍ R Casillo; M Grimaldi; E Ragone; C Maiello; C Marra; L De Santo; C Amarelli; G R 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB